Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Effect of Helicobacter pylori biofilm formation on susceptibility to amoxicillin, metronidazole and clarithromycin.

Yonezawa H, Osaki T, Hojo F, Kamiya S.

Microb Pathog. 2019 Jul;132:100-108. doi: 10.1016/j.micpath.2019.04.030. Epub 2019 Apr 26.

PMID:
31034965
2.

Enhanced infectivity of strains of Helicobacter pylori isolated from children compared with parental strains.

Zaman C, Osaki T, Furuta Y, Hojo F, Yonezawa H, Konno M, Kurata S, Hanawa T, Kamiya S.

J Med Microbiol. 2019 Apr;68(4):633-641. doi: 10.1099/jmm.0.000918. Epub 2019 Feb 26.

PMID:
30806617
3.

Highly Oriented Liquid Crystalline Epoxy Film: Robust High Thermal-Conductive Ability.

Tanaka S, Hojo F, Takezawa Y, Kanie K, Muramatsu A.

ACS Omega. 2018 Mar 27;3(3):3562-3570. doi: 10.1021/acsomega.7b02088. eCollection 2018 Mar 31.

4.

Influence of Intestinal Indigenous Microbiota on Intrafamilial Infection by Helicobacter pylori in Japan.

Osaki T, Zaman C, Yonezawa H, Lin Y, Okuda M, Nozaki E, Hojo F, Kurata S, Hanawa T, Kikuchi S, Kamiya S.

Front Immunol. 2018 Feb 21;9:287. doi: 10.3389/fimmu.2018.00287. eCollection 2018.

5.

Diversification of the AlpB Outer Membrane Protein of Helicobacter pylori Affects Biofilm Formation and Cellular Adhesion.

Yonezawa H, Osaki T, Fukutomi T, Hanawa T, Kurata S, Zaman C, Hojo F, Kamiya S.

J Bacteriol. 2017 Feb 28;199(6). pii: e00729-16. doi: 10.1128/JB.00729-16. Print 2017 Mar 15.

6.

Analysis of intra-familial transmission of Helicobacter pylori in Japanese families.

Osaki T, Konno M, Yonezawa H, Hojo F, Zaman C, Takahashi M, Fujiwara S, Kamiya S.

J Med Microbiol. 2015 Jan;64(Pt 1):67-73. doi: 10.1099/jmm.0.080507-0. Epub 2014 Oct 28.

PMID:
25351712
7.

Evaluation of a stool antigen test using a mAb for native catalase for diagnosis of Helicobacter pylori infection in children and adults.

Okuda M, Osaki T, Kikuchi S, Ueda J, Lin Y, Yonezawa H, Maekawa K, Hojo F, Kamiya S, Fukuda Y.

J Med Microbiol. 2014 Dec;63(Pt 12):1621-5. doi: 10.1099/jmm.0.077370-0. Epub 2014 Oct 20.

PMID:
25332372
8.

Multilocus sequence typing of DNA from faecal specimens for the analysis of intra-familial transmission of Helicobacter pylori.

Osaki T, Okuda M, Ueda J, Konno M, Yonezawa H, Hojo F, Yagyu K, Lin Y, Fukuda Y, Kikuchi S, Kamiya S.

J Med Microbiol. 2013 May;62(Pt 5):761-5. doi: 10.1099/jmm.0.053140-0. Epub 2013 Feb 7.

PMID:
23393109
9.

Ciliates expel environmental Legionella-laden pellets to stockpile food.

Hojo F, Sato D, Matsuo J, Miyake M, Nakamura S, Kunichika M, Hayashi Y, Yoshida M, Takahashi K, Takemura H, Kamiya S, Yamaguchi H.

Appl Environ Microbiol. 2012 Aug;78(15):5247-57. doi: 10.1128/AEM.00421-12. Epub 2012 May 25.

10.

Inhibition of the cytotoxic effect of Clostridium difficile in vitro by Clostridium butyricum MIYAIRI 588 strain.

Woo TD, Oka K, Takahashi M, Hojo F, Osaki T, Hanawa T, Kurata S, Yonezawa H, Kamiya S.

J Med Microbiol. 2011 Nov;60(Pt 11):1617-25. doi: 10.1099/jmm.0.033423-0. Epub 2011 Jun 23.

PMID:
21700738
11.

Analysis of outer membrane vesicle protein involved in biofilm formation of Helicobacter pylori.

Yonezawa H, Osaki T, Woo T, Kurata S, Zaman C, Hojo F, Hanawa T, Kato S, Kamiya S.

Anaerobe. 2011 Dec;17(6):388-90. doi: 10.1016/j.anaerobe.2011.03.020. Epub 2011 Apr 16.

PMID:
21515394
12.

Highly thermoconductive polymer nanocomposite with a nanoporous alpha-alumina sheet.

Shimazaki Y, Hojo F, Takezawa Y.

ACS Appl Mater Interfaces. 2009 Feb;1(2):225-7. doi: 10.1021/am800055s.

PMID:
20353204
13.

Systemic arterial supply to the normal basal segments of the left lower lobe treated by coil embolization, with long-term follow-up.

Saida T, Ninomiya H, Hojo F, Nakayama M, Yamauchi T, Saida Y.

Radiat Med. 2006 Jun;24(5):365-8.

PMID:
16958415
14.

The lung cancer database project at the National Cancer Center, Japan: study design, corresponding rate and profiles of cohort.

Nakaya N, Goto K, Saito-Nakaya K, Inagaki M, Otani T, Akechi T, Nagai K, Hojo F, Uchitomi Y, Tsugane S, Nishiwaki Y.

Jpn J Clin Oncol. 2006 May;36(5):280-4. Epub 2006 May 19.

PMID:
16714298
16.

Phase I/II trial of weekly cisplatin, etoposide, and irinotecan chemotherapy for metastatic lung cancer: JCOG 9507.

Sekine I, Nishiwaki Y, Kakinuma R, Kubota K, Hojo F, Matsumoto T, Ohmatsu H, Goto K, Kodama T, Eguchi K, Shinkai T, Tamura T, Ohe Y, Kunitoh H, Yoshimura K, Saijo N.

Br J Cancer. 2003 Mar 24;88(6):808-13.

17.

Serum levels of KL-6 are useful biomarkers for severe radiation pneumonitis.

Goto K, Kodama T, Sekine I, Kakinuma R, Kubota K, Hojo F, Matsumoto T, Ohmatsu H, Ikeda H, Ando M, Nishiwaki Y.

Lung Cancer. 2001 Oct;34(1):141-8.

PMID:
11557124
18.

Japanese experience of telemedicine in oncology.

Mizushima H, Uchiyama E, Nagata H, Matsuno Y, Sekiguchi R, Ohmatsu H, Hojo F, Shimoda T, Wakao F, Shinkai T, Yamaguchi N, Moriyama N, Kakizoe T, Abe K, Terada M.

Int J Med Inform. 2001 May;61(2-3):207-15.

PMID:
11311674
19.

Risk factors of treatment-related death in chemotherapy and thoracic radiotherapy for lung cancer.

Ohe Y, Yamamoto S, Suzuki K, Hojo F, Kakinuma R, Matsumoto T, Ohmatsu H, Nishiwaki Y.

Eur J Cancer. 2001 Jan;37(1):54-63.

PMID:
11165130
20.

Low-grade B-cell lymphoma of mucosa-associated lymphoid tissue in the thymus of a patient with pulmonary amyloid nodules.

Moriyama E, Yokose T, Kodama T, Matsuno Y, Hojo F, Takahashi K, Nagai K, Nishiwaki Y, Ochiai A.

Jpn J Clin Oncol. 2000 Aug;30(8):349-53. Review.

PMID:
11059340
21.

Effect of nebulized morphine in cancer patients with dyspnea: a pilot study.

Tanaka K, Shima Y, Kakinuma R, Kubota K, Ohe Y, Hojo F, Matsumoto T, Ohmatsu H, Goto K, Nagai K, Nishiwaki Y.

Jpn J Clin Oncol. 1999 Dec;29(12):600-3.

PMID:
10721941
22.

Phase I study of cisplatin and docetaxel plus mitomycin C in patients with metastatic non-small cell lung cancer.

Hosomi Y, Ohe Y, Mito K, Uramoto H, Moriyama E, Tanaka K, Kodama K, Niho S, Goto K, Ohmatsu H, Matsumoto T, Hojo F, Kakinuma R, Nishiwaki Y.

Jpn J Clin Oncol. 1999 Nov;29(11):546-9.

PMID:
10678557
23.

Significance of serum pro-gastrin-releasing peptide as a predictor of relapse of small cell lung cancer: comparative evaluation with neuron-specific enolase and carcinoembryonic antigen.

Niho S, Nishiwaki Y, Goto K, Ohmatsu H, Matsumoto T, Hojo F, Ohe Y, Kakinuma R, Kodama T.

Lung Cancer. 2000 Mar;27(3):159-67.

PMID:
10699689
24.

Primary unknown cancer in pulmonary hilar lymph node with spontaneous transient regression: report of a case.

Kawasaki H, Yoshida J, Yokose T, Suzuki K, Nagai K, Hojo F, Kodama T, Nishiwaki Y.

Jpn J Clin Oncol. 1998 Jun;28(6):405-9.

PMID:
9730158
25.

[Comparison of screening-detected and symptomatic lung cancer patients].

Nishiwaki Y, Hojo F, Omatsu H, Nagai K.

Gan To Kagaku Ryoho. 1998 Aug;25(10):1486-92. Review. Japanese.

PMID:
9725038
26.

Clinicopathologic characteristics of patients with nonsmall cell lung carcinoma with elevated serum progastrin-releasing peptide levels.

Goto K, Kodama T, Hojo F, Kubota K, Kakinuma R, Matsumoto T, Ohmatsu H, Sekine I, Nagai K, Nishiwaki Y.

Cancer. 1998 Mar 15;82(6):1056-61.

PMID:
9506349
27.

Second-line chemotherapy for relapsed small cell lung cancer.

Ebi N, Kubota K, Nishiwaki Y, Hojo F, Matsumoto T, Kakinuma R, Ohmatsu H, Sekine I, Yokosaki M, Gotoh K, Yamamoto H, Kodama T.

Jpn J Clin Oncol. 1997 Jun;27(3):166-9.

PMID:
9255271
28.

Phase II study of high-dose dexamethasone-based association in acute and delayed high-dose cisplatin-induced emesis--JCOG study 9413.

Sekine I, Nishiwaki Y, Kakinuma R, Kubota K, Hojo F, Matsumoto T, Ohmatsu H, Yokozaki M, Goto K, Miyamoto T, Takafuji J, Kodama T.

Br J Cancer. 1997;76(1):90-2.

29.

Dose-intensive weekly chemotherapy for treatment of relapsed small-cell lung cancer.

Kubota K, Nishiwaki Y, Kakinuma R, Hojo F, Matsumoto T, Ohmatsu H, Sekine I, Yokozaki M, Goto K, Ebi N, Kodama T.

J Clin Oncol. 1997 Jan;15(1):292-6.

PMID:
8996155
30.

Late recurrence of small-cell lung cancer: treatment and outcome.

Sekine I, Nishiwaki Y, Kakinuma R, Kubota K, Hojo F, Matsumoto T, Ohmatsu H, Yokozaki M, Goto K, Kodama T.

Oncology. 1996 Jul-Aug;53(4):318-21.

PMID:
8692537
31.

A randomized cross-over trial of granisetron and dexamethasone versus granisetron alone: the role of dexamethasone on day 1 in the control of cisplatin-induced delayed emesis.

Sekine I, Nishiwaki Y, Kakinuma R, Kubota K, Hojo F, Matsumoto T, Ohmatsu H, Yokozaki M, Kodama T.

Jpn J Clin Oncol. 1996 Jun;26(3):164-8.

PMID:
8656557
32.
33.

Pharmacokinetics of bronchial artery infusion of mitomycin in patients with non-small cell lung cancer.

Shimizu E, Nakamura Y, Mukai J, Tani K, Yamashita T, Hojo F, Hashimoto Y, Ogura T.

Eur J Cancer. 1991;27(8):1046-8.

PMID:
1654961
34.

[A phase II study of UFT in non-small cell lung cancer].

Shimizu E, Kimura K, Sone S, Inoue I, Nakamura Y, Noda Y, Hojo F, Yagi M, Nakanishi S, Yamasaki K, et al.

Gan To Kagaku Ryoho. 1986 Oct;13(10):2970-3. Japanese.

PMID:
3021068
35.

[Pharmacokinetics of mitomycin C (MMC) after infusion into the bronchial artery].

Shimizu E, Hojo F, Nakamura Y, Hashimoto Y, Mutsuura S, Inoue I, Tada T, Sone S, Yamashita T, Ogura T.

Gan To Kagaku Ryoho. 1986 Apr;13(4 Pt 1):1086-8. Japanese. No abstract available.

PMID:
3083787
36.

Japanese encephalitis purified vaccine. II. Purity of the mouse brain vaccine purified by ultracentrifugation.

Yamashita T, Ishikawa N, Hojo F, Shimada F, Ono K.

Biken J. 1970 Mar;13(1):25-38. No abstract available.

PMID:
4193086

Supplemental Content

Support Center